Jazz Pharmaceuticals PLC (JAZZ)
108.32
-1.35
(-1.23%)
USD |
NASDAQ |
Apr 24, 16:00
108.32
0.00 (0.00%)
After-Hours: 20:00
Jazz Pharmaceuticals Cash from Operations (Quarterly): 167.34M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 167.34M |
| September 30, 2023 | 307.20M |
| June 30, 2023 | 296.76M |
| March 31, 2023 | 320.71M |
| December 31, 2022 | 341.97M |
| September 30, 2022 | 417.99M |
| June 30, 2022 | 303.04M |
| March 31, 2022 | 208.98M |
| December 31, 2021 | 177.76M |
| September 30, 2021 | 274.06M |
| June 30, 2021 | 41.70M |
| March 31, 2021 | 285.00M |
| December 31, 2020 | 186.27M |
| September 30, 2020 | 257.89M |
| June 30, 2020 | 182.52M |
| March 31, 2020 | 272.97M |
| December 31, 2019 | 87.80M |
| September 30, 2019 | 337.50M |
| June 30, 2019 | 148.85M |
| March 31, 2019 | 202.25M |
| December 31, 2018 | 218.10M |
| September 30, 2018 | 221.48M |
| June 30, 2018 | 191.97M |
| March 31, 2018 | 167.36M |
| December 31, 2017 | 204.56M |
| Date | Value |
|---|---|
| September 30, 2017 | 188.90M |
| June 30, 2017 | 135.09M |
| March 31, 2017 | 164.54M |
| December 31, 2016 | 180.70M |
| September 30, 2016 | 133.03M |
| June 30, 2016 | 127.01M |
| March 31, 2016 | 151.65M |
| December 31, 2015 | 119.74M |
| September 30, 2015 | 175.08M |
| June 30, 2015 | 140.57M |
| March 31, 2015 | 96.56M |
| December 31, 2014 | 134.26M |
| September 30, 2014 | 129.70M |
| June 30, 2014 | 74.92M |
| March 31, 2014 | 68.72M |
| December 31, 2013 | 79.03M |
| September 30, 2013 | 130.79M |
| June 30, 2013 | 8.719M |
| March 31, 2013 | 69.89M |
| December 31, 2012 | 104.34M |
| September 30, 2012 | 44.14M |
| June 30, 2012 | 76.97M |
| March 31, 2012 | 24.30M |
| December 31, 2011 | 43.66M |
| September 30, 2011 | 46.05M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
41.70M
Minimum
Jun 2021
417.99M
Maximum
Sep 2022
242.96M
Average
272.97M
Median
Mar 2020
Cash from Operations (Quarterly) Benchmarks
| Alkermes PLC | 107.24M |
| Endo International PLC | 115.06M |
| Medtronic PLC | 2.474B |
| Perrigo Co PLC | 208.70M |
| Iterum Therapeutics PLC | -12.84M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 101.80M |
| Cash from Financing (Quarterly) | -100.31M |
| Free Cash Flow | 1.049B |
| Free Cash Flow Per Share (Quarterly) | 1.999 |
| Free Cash Flow to Equity (Quarterly) | 141.56M |
| Free Cash Flow to Firm (Quarterly) | 247.38M |
| Free Cash Flow Yield | 13.44% |